Literature DB >> 21682268

Active site gating and substrate specificity of butyrylcholinesterase and acetylcholinesterase: insights from molecular dynamics simulations.

Lei Fang1, Yongmei Pan, Jennifer L Muzyka, Chang-Guo Zhan.   

Abstract

Butyrylcholinesterase (BChE) and acetylcholinesterase (AChE) are highly homologous proteins with distinct substrate preferences. In this study we compared the active sites of monomers and tetramers of human BChE and human AChE after performing molecular dynamics (MD) simulations in water-solvated systems. By comparing the conformational dynamics of gating residues of AChE and BChE, we found that the gating mechanisms of the main door of AChE and BChE are responsible for their different substrate specificities. Our simulation of the tetramers of AChE and BChE indicates that both enzymes could have two dysfunctional active sites due to their restricted accessibility to substrates. The further study on catalytic mechanisms of multiple forms of AChE and BChE would benefit from our comparison of the active sites of the monomers and tetramers of both enzymes.
© 2011 American Chemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21682268      PMCID: PMC3135420          DOI: 10.1021/jp112030p

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  33 in total

1.  A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations.

Authors:  Yong Duan; Chun Wu; Shibasish Chowdhury; Mathew C Lee; Guoming Xiong; Wei Zhang; Rong Yang; Piotr Cieplak; Ray Luo; Taisung Lee; James Caldwell; Junmei Wang; Peter Kollman
Journal:  J Comput Chem       Date:  2003-12       Impact factor: 3.376

2.  Conformation gating as a mechanism for enzyme specificity.

Authors:  H X Zhou; S T Wlodek; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

3.  Influence of the acetylcholinesterase active site protonation on omega loop and active site dynamics.

Authors:  Jiří Wiesner; Zdeněk Kříž; Kamil Kuča; Daniel Jun; Jaroslav Koča
Journal:  J Biomol Struct Dyn       Date:  2010-12

4.  Solvent-accessible surfaces of proteins and nucleic acids.

Authors:  M L Connolly
Journal:  Science       Date:  1983-08-19       Impact factor: 47.728

5.  Mouse acetylcholinesterase unliganded and in complex with huperzine A: a comparison of molecular dynamics simulations.

Authors:  S Tara; T P Straatsma; J A McCammon
Journal:  Biopolymers       Date:  1999-07       Impact factor: 2.505

Review 6.  Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy.

Authors:  D A Gorelick
Journal:  Drug Alcohol Depend       Date:  1997-12-15       Impact factor: 4.492

7.  Molecular dynamics simulations of human butyrylcholinesterase.

Authors:  Dimas Suárez; Martin J Field
Journal:  Proteins       Date:  2005-04-01

8.  Wild-type and A328W mutant human butyrylcholinesterase tetramers expressed in Chinese hamster ovary cells have a 16-hour half-life in the circulation and protect mice from cocaine toxicity.

Authors:  Ellen G Duysen; Cynthia F Bartels; Oksana Lockridge
Journal:  J Pharmacol Exp Ther       Date:  2002-08       Impact factor: 4.030

9.  Model of human butyrylcholinesterase tetramer by homology modeling and dynamics simulation.

Authors:  Yongmei Pan; Jennifer L Muzyka; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2009-05-07       Impact factor: 2.991

10.  Crystal structure of mouse acetylcholinesterase. A peripheral site-occluding loop in a tetrameric assembly.

Authors:  Y Bourne; P Taylor; P E Bougis; P Marchot
Journal:  J Biol Chem       Date:  1999-01-29       Impact factor: 5.157

View more
  15 in total

1.  Fundamental reaction pathway and free energy profile for butyrylcholinesterase-catalyzed hydrolysis of heroin.

Authors:  Yan Qiao; Keli Han; Chang-Guo Zhan
Journal:  Biochemistry       Date:  2013-08-30       Impact factor: 3.162

2.  Kinetic characterization of high-activity mutants of human butyrylcholinesterase for the cocaine metabolite norcocaine.

Authors:  Max Zhan; Shurong Hou; Chang-Guo Zhan; Fang Zheng
Journal:  Biochem J       Date:  2014-01-01       Impact factor: 3.857

3.  Ensemble Molecular Dynamics of a Protein-Ligand Complex: Residual Inhibitor Entropy Enhances Drug Potency in Butyrylcholinesterase.

Authors:  Eric J Sorin; Walter Alvarado; Samantha Cao; Amethyst Radcliffe; Phuc La; Yi An
Journal:  Bioenergetics       Date:  2017-01-08

Review 4.  Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease.

Authors:  Muriel Noetzli; Chin B Eap
Journal:  Clin Pharmacokinet       Date:  2013-04       Impact factor: 6.447

5.  Probing the Substrate Specificity and Protein-Protein Interactions of the E. coli Fatty Acid Dehydratase, FabA.

Authors:  Kara Finzel; Chi Nguyen; David R Jackson; Aarushi Gupta; Shiou-Chuan Tsai; Michael D Burkart
Journal:  Chem Biol       Date:  2015-10-29

6.  Diffusion control in biochemical specificity.

Authors:  Jose L Alejo; Christopher P Kempes; Katarzyna P Adamala
Journal:  Biophys J       Date:  2022-03-09       Impact factor: 3.699

7.  Novel human butyrylcholinesterase variants: toward organophosphonate detoxication.

Authors:  Mary Dwyer; Sacha Javor; Daniel A Ryan; Emily M Smith; Beilin Wang; Jun Zhang; John R Cashman
Journal:  Biochemistry       Date:  2014-06-30       Impact factor: 3.162

8.  A wrench in the works of human acetylcholinesterase: soman induced conformational changes revealed by molecular dynamics simulations.

Authors:  Brian J Bennion; Sebnem G Essiz; Edmond Y Lau; Jean-Luc Fattebert; Aiyana Emigh; Felice C Lightstone
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

9.  Gorge Motions of Acetylcholinesterase Revealed by Microsecond Molecular Dynamics Simulations.

Authors:  Shanmei Cheng; Wanling Song; Xiaojing Yuan; Yechun Xu
Journal:  Sci Rep       Date:  2017-06-12       Impact factor: 4.379

10.  Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer's Agents: Design, Synthesis and Biological Evaluation.

Authors:  Katarina Spilovska; Jan Korabecny; Vendula Sepsova; Daniel Jun; Martina Hrabinova; Petr Jost; Lubica Muckova; Ondrej Soukup; Jana Janockova; Tomas Kucera; Rafael Dolezal; Eva Mezeiova; Daniel Kaping; Kamil Kuca
Journal:  Molecules       Date:  2017-06-16       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.